An open repository of community-contributed protocols sponsored by Nature Research.
Learn more about Protocol Exchange
Method Article
Seyed Sina Naghibi Irvani
Shahid Beheshti University of Medical Sciences
Corresponding Author
ORCiD: https://orcid.org/0000-0002-4566-7402
Ilad Alavi Darazam
Shahid Beheshti University of Medical Sciences
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Study Title:
Effectiveness of Interferon Beta 1a and Interferon Beta 1b compared to the Usual Therapeutic Regimen to Treat Adults with Moderate to Severe COVID-19
Objectives:
We will investigate the effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen in COVID-19 in patients that have tested positive and are moderately to severely ill.
Trial Design:
This is a single center, open label, randomized, controlled, parallel group, clinical trial that will be conducted at Loghman Hakim hospital in conjunction with Shahid Beheshti University of Medical Sciences.
Keywords
COVID-19, 2019-nCoV, SARS-CoV-2, Interferon, Randomized Clinical Trial, COVIFERON.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Version History
CURRENT STATUS: Posted
Version 1
Posted 26 May, 2021
No community comments so far
Metrics
Comments: 0
HTML Views: ...
Associated Publications
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
by Seyed Sina Naghibi Irvani, Maryam Golmohammadi, Mohamad Amin Pourhoseingholi, +2
Trials (03 June, 2020)
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
by Ilad Alavi Darazam, Shervin Shokouhi, Mohamad Amin Pourhoseingholi, +19
Scientific Reports (13 April, 2021)
An open repository of community-contributed protocols sponsored by Nature Research.
Learn more about Protocol Exchange
Method Article
Seyed Sina Naghibi Irvani
Shahid Beheshti University of Medical Sciences
Corresponding Author
ORCiD: https://orcid.org/0000-0002-4566-7402
Ilad Alavi Darazam
Shahid Beheshti University of Medical Sciences
Corresponding Author
Version History
CURRENT STATUS: Posted
Version 1
Posted 26 May, 2021
No community comments so far
Metrics
Comments: 0
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Study Title:
Effectiveness of Interferon Beta 1a and Interferon Beta 1b compared to the Usual Therapeutic Regimen to Treat Adults with Moderate to Severe COVID-19
Objectives:
We will investigate the effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen in COVID-19 in patients that have tested positive and are moderately to severely ill.
Trial Design:
This is a single center, open label, randomized, controlled, parallel group, clinical trial that will be conducted at Loghman Hakim hospital in conjunction with Shahid Beheshti University of Medical Sciences.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Associated Publications
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
by Seyed Sina Naghibi Irvani, Maryam Golmohammadi, Mohamad Amin Pourhoseingholi, +2
Trials (03 June, 2020)
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
by Ilad Alavi Darazam, Shervin Shokouhi, Mohamad Amin Pourhoseingholi, +19
Scientific Reports (13 April, 2021)